“COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR: Infection With PTCy Versus Standard GvHD Prophylaxis” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024016. doi:10.4084/MJHID.2024.016.